Bioxytran, Inc (BIXT) stock

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30

$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

Bioxytran pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Bioxytran's pe ratio was 240.0× on Jan 30, 2015.

Period	Period end	Value	Change (pts)
2015	Jan 30, 2015	240.0×	+0.0
2014	Dec 31, 2014	240.0×	–

See a number that looks wrong?